Developer docs
API playgroundTry for free, no card

Search company profiles

MetaStat

Full company profile

uuid0007dpl

Namestring
MetaStat
Legal namestring
Metastat
Websiteurl
metastat.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

MetaStat is a clinical-stage biotechnology company developing diagnostic technologies and therapeutics for the early detection and treatment of systemic metastasis — cancer that has spread from a primary tumor to distant organs. Founded in 2010 and headquartered in Montclair, New Jersey, the company operates with a small team of 11-50 employees and has historically traded on the OTCQB market under the ticker MTST, though it is currently in a delisted status. MetaStat's core thesis targets the metastatic cascade, which is the leading cause of cancer-related mortality, by combining diagnostic detection with therapeutic intervention.

The company has funded its development through a series of ten private financing rounds between 2012 and 2017, collectively raising approximately $24.4 million, with the largest single round ($7.0M) closing in June 2017 and a second major tranche ($5.7M) in July 2014. Cumulative operating losses have been substantial across the disclosed period (EBITDA losses in the multi-million range annually through 2018), consistent with a clinical-stage R&D burn profile. Leadership comprises Douglas A. Hamilton (President & CEO) and Michael J. Donovan (Chief Medical Officer), reflecting an oncology-experienced management team.

MetaStat's business model is oriented toward eventual commercialization of proprietary diagnostics and therapeutics in the oncology space, though no specific pricing model, revenue mechanics, or commercial partnerships are disclosed in the available input. The company has not disclosed any API platform, technology integrations, AI/ML capabilities, patents, regulatory milestones, or named institutional customers/partners, leaving significant information gaps around the specific modality of its diagnostic and therapeutic platform, clinical pipeline status, and go-to-market strategy.

Short descriptiontext

MetaStat is a clinical-stage biotechnology company developing diagnostic technologies and therapeutics for the early detection and treatment of systemic metastasis, headquartered in Montclair, New Jersey.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMontclair, United States
HQ citystring
Montclair
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
paid media services, creator marketing agency, brand scaling services, performance advertising, digital ad management
Industry2 codes
1Influencer Media Amplification (Paid Creator Whitelisting/Spark Ads)
CodeMPAAABALPrimaryYes
2Creator Monetization Tools (Subscriptions, Tips, Merch)
CodeBPAMALAHPrimaryNo
NAICS code1 code
  • Media Representatives541840
SIC code1 code
  • Services-Advertising Agencies7311
Product category
Digital Marketing Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Paid Media Agency Services
TypeProfessional Services
Description

Metastat generates revenue by providing paid media management services to creator brands. They offer creative strategy, asset production, growth strategy, and Meta & Google Ads optimization as bundled service offerings. Revenue is derived from service fees charged to creator clients for campaign management and strategic consulting.

metastat.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

MetaStat is a creator economy marketing agency that helps content creators and influencers transform their audiences into scalable brands through paid media strategies. They deliver four integrated services—Creative Strategy, Creative Asset Production, Growth Strategy, and Meta & Google Ads Optimization—under a partnership model that positions the agency as an extension of creator teams. The team has collectively managed more than $250 million in paid media spend across over 100 creator ventures in sectors including fashion, beauty, fitness, beverages, and wellness.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

MetaStat is a creator-focused paid media agency that operates as a unified service offering rather than a software platform. The company provides four integrated services: Creative Strategy (storytelling and audience insight), Creative Asset Production (leveraging advanced AI and editing tools), Growth Strategy (reaching net-new audiences), and Meta & Google Ads Optimization (real-time campaign optimization). These services work together as a growth engine—creative briefs flow through strategy, production, and performance optimization—to help creators transform their audiences into scalable brands and ventures.

Product and service1 record
1Creative Strategy
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeOthers
Description

Creator-led fashion brand partnership. Grace Beverly is one of the world's biggest creators who has built a scalable brand with Metastat's help. Featured as a flagship case study demonstrating the creator-to-brand transformation model.

Strategic tierCoreTypeOthers
Description

Creator-led beauty brand partnership. Jamie Genevieve is a prominent beauty creator who launched Vieve brand. Metastat has helped scale the brand, featured as a flagship case study on the world's biggest creator brands.

Strategic tierCoreTypeOthers
Description

Creator-led activewear brand partnership. Krissy Cela launched Oner Active fitness brand. Featured as a key case study demonstrating successful creator brand scaling through Metastat's paid media expertise.

Strategic tierCoreTypeOthers
Description

Creator-led beverage brand partnership. KSI's Prime hydration brand has been a major success, selling out 3 years running with 50%+ of ticket sales via paid media and 100M+ yearly paid impressions. Flagship case study for Metastat.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Market position
Competitive moat2 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MetaStat

Digital Marketing Servicesmetastat.com

MetaStat is a clinical-stage biotechnology company developing diagnostic technologies and therapeutics for the early detection and treatment of systemic metastasis, headquartered in Montclair, New Jersey.

What MetaStat does

MetaStat is a clinical-stage biotechnology company developing diagnostic technologies and therapeutics for the early detection and treatment of systemic metastasis — cancer that has spread from a primary tumor to distant organs. Founded in 2010 and headquartered in Montclair, New Jersey, the company operates with a small team of 11-50 employees and has historically traded on the OTCQB market under the ticker MTST, though it is currently in a delisted status. MetaStat's core thesis targets the metastatic cascade, which is the leading cause of cancer-related mortality, by combining diagnostic detection with therapeutic intervention.

The company has funded its development through a series of ten private financing rounds between 2012 and 2017, collectively raising approximately $24.4 million, with the largest single round ($7.0M) closing in June 2017 and a second major tranche ($5.7M) in July 2014. Cumulative operating losses have been substantial across the disclosed period (EBITDA losses in the multi-million range annually through 2018), consistent with a clinical-stage R&D burn profile. Leadership comprises Douglas A. Hamilton (President & CEO) and Michael J. Donovan (Chief Medical Officer), reflecting an oncology-experienced management team.

MetaStat's business model is oriented toward eventual commercialization of proprietary diagnostics and therapeutics in the oncology space, though no specific pricing model, revenue mechanics, or commercial partnerships are disclosed in the available input. The company has not disclosed any API platform, technology integrations, AI/ML capabilities, patents, regulatory milestones, or named institutional customers/partners, leaving significant information gaps around the specific modality of its diagnostic and therapeutic platform, clinical pipeline status, and go-to-market strategy.

MetaStat firmographics

Firmographics
Name
MetaStat
Legal name
Metastat
Website
https://metastat.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
MetaStat is a clinical-stage biotechnology company developing diagnostic technologies and therapeutics for the early detection and treatment of systemic metastasis, headquartered in Montclair, New Jersey.
Ownership category
akta.pro rank

MetaStat industry classification

Industry
Product category
Digital Marketing Services
NAICS
Media Representatives (541840)
SIC
Services-Advertising Agencies (7311)
akta.pro primary industry
Influencer Media Amplification (Paid Creator Whitelisting/Spark Ads) (MPAAABAL)
akta.pro secondary industry
Creator Monetization Tools (Subscriptions, Tips, Merch) (BPAMALAH)

Keywords

  • Paid media services
  • Creator marketing agency
  • Brand scaling services
  • Performance advertising
  • Digital ad management

Where MetaStat is headquartered

Location

Headquarters

HQ city
Montclair
HQ country
United States
HQ region
North America

Markets served

MetaStat business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

  1. Paid Media Agency Services: Metastat generates revenue by providing paid media management services to creator brands. They offer creative strategy, asset production, growth strategy, and Meta & Google Ads optimization as bundled service offerings. Revenue is derived from service fees charged to creator clients for campaign management and strategic consulting.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

MetaStat product offering

Product offering

Core offering

MetaStat is a creator economy marketing agency that helps content creators and influencers transform their audiences into scalable brands through paid media strategies. They deliver four integrated services—Creative Strategy, Creative Asset Production, Growth Strategy, and Meta & Google Ads Optimization—under a partnership model that positions the agency as an extension of creator teams. The team has collectively managed more than $250 million in paid media spend across over 100 creator ventures in sectors including fashion, beauty, fitness, beverages, and wellness.

Product overview

MetaStat is a creator-focused paid media agency that operates as a unified service offering rather than a software platform. The company provides four integrated services: Creative Strategy (storytelling and audience insight), Creative Asset Production (leveraging advanced AI and editing tools), Growth Strategy (reaching net-new audiences), and Meta & Google Ads Optimization (real-time campaign optimization). These services work together as a growth engine—creative briefs flow through strategy, production, and performance optimization—to help creators transform their audiences into scalable brands and ventures.

Differentiator

Problem solved

Functional benefit

Products and services

  • Creative Strategy

Companies that use MetaStat

Customer profile

Named customers7 records

Segments1 record

Ideal customer profiles2 records

MetaStat technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

MetaStat partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • TALA (Grace Beverly)coreOthersCreator-led fashion brand partnership. Grace Beverly is one of the world's biggest creators who has built a scalable brand with Metastat's help. Featured as a flagship case study demonstrating the creator-to-brand transformation model.
  • Vieve (Jamie Genevieve)coreOthersCreator-led beauty brand partnership. Jamie Genevieve is a prominent beauty creator who launched Vieve brand. Metastat has helped scale the brand, featured as a flagship case study on the world's biggest creator brands.
  • Oner Active (Krissy Cela)coreOthersCreator-led activewear brand partnership. Krissy Cela launched Oner Active fitness brand. Featured as a key case study demonstrating successful creator brand scaling through Metastat's paid media expertise.
  • Prime (KSI)coreOthersCreator-led beverage brand partnership. KSI's Prime hydration brand has been a major success, selling out 3 years running with 50%+ of ticket sales via paid media and 100M+ yearly paid impressions. Flagship case study for Metastat.

Scale indicators9 records

Recent moves4 records

Expansion highlights3 records

MetaStat competitors and assessment

Company assessment

Market position

Competitive moat2 records

Key risks4 records

Key highlights6 records

Customer concentration

MetaStat social profiles

Digital presence

MetaStat financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MetaStat leadership team

Management profile

Number of profiles

Profiles1 record

MetaStat funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MetaStat M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MetaStat

What does MetaStat do?

MetaStat is a creator economy marketing agency that helps content creators and influencers transform their audiences into scalable brands through paid media strategies. They deliver four integrated services—Creative Strategy, Creative Asset Production, Growth Strategy, and Meta & Google Ads Optimization—under a partnership model that positions the agency as an extension of creator teams. The team has collectively managed more than $250 million in paid media spend across over 100 creator ventures in sectors including fashion, beauty, fitness, beverages, and wellness.

Is MetaStat a public or private company?

MetaStat is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MetaStat founded?

MetaStat was founded in 2010. It employs 11 to 50 people.

Where is MetaStat based?

MetaStat is headquartered in Montclair, United States, in the North America region.

How does MetaStat make money?

One revenue line is on record: paid Media Agency Services.

Does MetaStat have an API?

No public API is recorded for MetaStat.

What industry is MetaStat in?

MetaStat's product category is Digital Marketing Services. Its primary akta.pro industry code is MPAAABAL, Influencer Media Amplification (Paid Creator Whitelisting/Spark Ads), with a secondary code of BPAMALAH, Creator Monetization Tools (Subscriptions, Tips, Merch). Its NAICS code is 541840 and its SIC code is 7311.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Defense WorldMetastat (OTCMKTS:MTST) & Evolus (NASDAQ:EOLS) Critical AnalysisAnalysts favor Evolus (NASDAQ:EOLS) over Metastat (OTCMKTS:MTST) based on stronger institutional ownership (90.7% vs. unknown), a higher analyst consensus rating (2.50 vs. 0.00), and greater potential upside (274.71% to $16.00 target). Metastat shows significantly higher volatility with a beta of 295.91 compared to Evolus's beta of 1, while Evolus reports $297.18 million in gross revenue but negative earnings of -$51.64 million. The comparison is part of a broader stock screening exercise evaluating nine financial metrics between the two medical and aesthetics companies.Metastat InsightGlobal Longevity Supplements Market Expected to Reach USD 16.7 Billion by 2033: New Report by Metastat InsightThe global longevity supplements market is projected to grow from USD 9.9 billion to USD 16.7 billion by 2033, representing a CAGR of 7.8%, driven by consumer shifts toward preventive healthcare and cellular health. The report highlights key growth ingredients including NAD+ boosters, polyphenols, adaptogenic botanicals, and probiotics, as well as innovations in delivery formats and clinical validation. Regional adoption varies significantly across global markets, with industry credibility being bolstered by evidence-backed claims and ethical sourcing.Metastat Insight1 new messageMetastat Insight published a study on the transformation of the global warehouse management market, highlighting its shift from a back-end function to a strategic component influenced by digital tools, workforce coordination, and regional diversification. The market is expected to reach $4,646.93 million by 2025 with a CAGR of 16.4%, emphasizing customization, technological integration, and sustainability. This evolution enhances warehouses' role as operational hubs that provide competitive advantages to businesses.Metastat Insight1 new messageMetastat Insight released a market research report estimating the global conveyor systems market will reach $11,042.61 million in 2025, growing at a compound annual growth rate of 6.0% through 2032. The report highlights how conveyor systems are evolving from utilitarian tools into strategic resources integrated with automation, digital monitoring, and sustainability initiatives across industries including food processing and automotive manufacturing. Industry stakeholders are increasingly focusing on customization, equipment longevity, and human-machine interaction as key factors shaping the market's transformation.openPR.comWestern Wear Market Estimated to Grow by 5.8% CAGR, Value to Worth $133,971.7 Million by 2030 | MetastatMetastat Insight published a market research report projecting that the Western Wear Market will grow at a 5.8% CAGR, reaching a value of $133,971.7 million by 2030. The report attributes this growth to factors including the fusion of traditional Western elements with modern design, the rise of e-commerce, and increasing global fascination with Western aesthetics. Key players identified in the report include Levi Strauss & Co., Kontoor Brands, Inditex (Zara), The Gap, H&M, and Ariat International, among others.GlobeNewswireSamaritan Arrives at Definitive Agreement to Acquire Metastatin to Expand Cancer PipelineSamaritan Pharmaceuticals announced a definitive agreement to acquire Metastatin Pharmaceuticals, a cancer drug developer, for 500,000 restricted shares. The deal, approved by Samaritan's board, is expected to close upon Metastatin shareholder approval. The acquisition expands Samaritan's oncology pipeline.